U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07231965) titled 'Synthetic THC And Blood Pressure' on Nov. 13.
Brief Summary: To investigate the effects of Dronabinol use on blood pressure and neurovascular physiology
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Blood Pressure
Intervention:
DRUG: Dronabinol
Patients will take one 10 mg dose of Dronabinol.
DRUG: Placebo
Patients will take one 10mg dose of a Placebo Pill.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Mayo Clinic
Information provided by (Responsible Party): Virend Somers, MD, PhD, Mayo Clinic
Published by HT Digital Content Services with permission from Health Daily Digest....